Key Takeaways
- TSMC’s advanced 2nm manufacturing capacity is completely reserved through 2028 and likely beyond
- The capacity shortage could require NVIDIA to completely rework its Feynman AI platform architecture
- Meta and other tech giants are vying for the same limited TSMC production slots
- TSMC plans consecutive price increases annually until 2029 driven by unprecedented demand
- Wall Street analysts continue to recommend NVDA as a Strong Buy with a $274.03 average target price
Shares of NVIDIA stumbled on Monday following reports that severe manufacturing constraints at Taiwan Semiconductor Manufacturing Company could derail the chipmaker’s ambitious Feynman AI platform roadmap. NVDA closed down 3.28%, while TSM shares retreated 2.82%.
According to a report initially published by Taiwan’s Economic Daily News, TSMC’s cutting-edge 2-nanometer production lines are operating at maximum capacity with orders stretching to 2028 and potentially further into the future. The unprecedented wave of demand from artificial intelligence and high-performance computing sectors has created a significant supply bottleneck at the planet’s premier semiconductor foundry.
Feynman represents NVIDIA’s forthcoming data center platform architecture, which was introduced at the company’s GTC 2026 conference. This platform is intended to replace the Vera Rubin architecture and is targeted for market entry in 2028.
The core challenge is straightforward: TSMC may lack sufficient 2nm production capacity to manufacture Feynman according to its original specifications. This reality is compelling NVIDIA to explore alternative design approaches years before the platform’s anticipated launch.
Multiple Tech Giants Compete for Limited TSMC Resources
TSMC’s 2nm process nodes, including the sophisticated A16 variation, deliver performance and efficiency improvements ranging from 15-25% compared to previous-generation manufacturing technologies. These advantages make them exceptionally desirable for energy-intensive artificial intelligence applications.
NVIDIA faces stiff competition for these manufacturing slots. Meta has emerged as an aggressive competitor, placing substantial orders for specialized AI processors and graphics chips destined for its expanding data center infrastructure. Apple currently commands more than half of initial 2nm production allocations, relegating other customers to later delivery windows.
Reports indicate NVIDIA controls approximately 20% of TSMC’s most advanced production capacity and has reserved the majority of CoWoS advanced packaging capabilities through 2026. CEO Jensen Huang has reportedly engaged directly with TSMC leadership to maximize production allocation.
Despite this preferential treatment, even NVIDIA cannot escape the capacity constraints. Customer reservation queues now stretch past 2028, and TSMC has communicated intentions to implement yearly price escalations through 2029 to address escalating production expenses.
Vera Rubin Platform Remains on Schedule
While Feynman encounters potential obstacles, NVIDIA’s more immediate Vera Rubin platform continues progressing according to plan. Vera Rubin is scheduled to commence shipments in the coming months, well ahead of Feynman’s timeline.
NVIDIA has also successfully secured A16 manufacturing allocations for its Rubin Ultra architecture and subsequent GPU generations following Vera Rubin. The manufacturing shortage appears most critical for the Feynman platform, which occupies a later position in the company’s development roadmap.
TSMC has publicly recognized the surge in customer demand and indicated plans to augment production capacity gradually. However, the company has not provided specific timelines for when the current capacity constraints might ease.
Industry observers have mentioned Intel and Samsung as possible alternative manufacturing partners, although neither competitor currently delivers TSMC’s leading-edge process technology at comparable production volumes.
Financial analysts tracking NVDA maintain an optimistic long-term outlook. According to TipRanks data, the stock holds a Strong Buy consensus rating from 41 analysts, with only a single Hold recommendation. The consensus price target stands at $274.03, representing approximately 58.7% potential upside from present trading levels.
NVDA concluded Monday’s session down 3.28%. TSM shares declined 2.82% during the same trading period.
